A detailed history of Cantor Fitzgerald, L. P. transactions in Novo Nordisk A S stock. As of the latest transaction made, Cantor Fitzgerald, L. P. holds 7,796 shares of NVO stock, worth $1.11 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
7,796
Holding current value
$1.11 Million
% of portfolio
0.15%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $796,049 - $1.06 Million
7,796 New
7,796 $1 Million
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $328,160 - $433,056
3,200 New
3,200 $433,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $323B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Cantor Fitzgerald, L. P. Portfolio

Follow Cantor Fitzgerald, L. P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cantor Fitzgerald, L. P., based on Form 13F filings with the SEC.

News

Stay updated on Cantor Fitzgerald, L. P. with notifications on news.